Shockwave Treatment Enhanced Extracellular Matrix Production in Articular Chondrocytes Through Activation of the ROS/MAPK/Nrf2 Signaling Pathway

Abstract

Objective Shockwave application is a potential treatment for osteoarthritis (OA), but the underlying mechanism remains unknown. Oxidative stress and a counterbalancing antioxidant system might be the key to understanding this mechanism. We hypothesized that reactive oxygen species (ROS) and the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2),which is an important regulator of cellular redox homeostasis, are plausible elements. Design Porcine chondrocytes were cultured in a 3-dimensional pellet model and subjected to shockwaves. The effects of shockwaves with various energy-flux densities on optimal extracellular matrix (ECM) synthesis were assessed. ROS, mitogen-activated protein kinase (MAPK) signaling, and the redox activity of Nrf2 were measured. To investigate the signaling mechanism involved in the shockwave treatment in chondrocytes, specific inhibitors of ROS, MAPK signaling, and Nrf2 activity were targeted. Results Shockwaves increased ECM synthesis without affecting cell viability or proliferation. Furthermore, they induced transient ROS production mainly through xanthine oxidase. The phosphorylation of ERK1/2 and p38 and the nuclear translocation of Nrf2 were activated by shockwaves. By contrast, suppression of ROS signaling mitigated shockwave-induced MAPK phosphorylation, Nrf2 nuclear translocation, and ECM synthesis. Pretreatment of chondrocytes with the specific inhibitors of MEK1/2 and p38, respectively, mitigated the shockwave-induced nuclear translocation of Nrf2 and ECM synthesis. Nrf2 inhibition by both small hairpin RNA knockdown and brusatol reduced the shockwave-enhanced ECM synthesis. Conclusions Shockwaves activated Nrf2 activity through the induction of transient ROS signaling and subsequently enhanced ECM synthesis in chondrocytes. This study provided fundamental evidence confirming the potential of shockwaves for OA management.

Carnosine Alleviates Knee Osteoarthritis and Promotes Synoviocyte Protection via Activating the Nrf2/HO-1 Signaling Pathway: An In-Vivo and In-Vitro Study

“…In a recent study, a sulforaphane-activated Nrf2 signaling pathway was found to reduce allodynia and hyperalgesia while augmenting morphine’s antinociception [ 110 ]. Furthermore, a recent study found that activating Nrf2 reduced nociceptive hypersensitivity by reducing mitochondrial dysfunction and neuro-inflammation in a dimethyl fumarate-induced peripheral nerve injury model [ 111 ]. These findings suggest that the Nrf2 signaling pathway may be a promising therapeutic approach for chronic pain associated with knee OA treatment [ 112 , 113 , 114 ].…”

Mechanotransduction pathways in articular chondrocytes and the emerging role of estrogen receptor-α

“… Nrf2 inhibition reduces shockwave-enhanced ECM synthesis. 144 Sox9 Primary chondrocytes isolated from bovine calves Physiological tensile strain (7.5% elongation, 1 Hz, 30 min) is applied. Physiological tensile strain induces SOX9 transcription and expression.…”

Suramin enhances chondrogenic properties by regulating the p67phox/PI3K/AKT/SOX9 signalling pathway

“… 43 In our recent report, we found that shockwave treatment enhanced ECM synthesis in ACs through activation of the ROS/MAPK/NRF2 signalling pathway. 44 Furthermore, another study showed that increased stiffness and appropriate ROS production facilitates the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) by activating the mechanistic target of rapamycin (mTOR) signalling pathway. 45 Therefore, ROS are not categorically harmful, and therapeutics must consider the essential role of ROS levels.…”